Literature DB >> 3923157

Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.

E Kelly, P Jenner, C D Marsden.   

Abstract

Potassium chloride (25 mM) and (+)-amphetamine (100 microM) both stimulated the release of radioactivity from slices of substantia nigra preincubated with [3H]3,4-dihydroxyphenylethylamine [( 3H]dopamine). Potassium chloride (25 mM) released radioactivity from slices of both zona compacta and zona reticulata. Prior 6-hydroxydopamine (6-OHDA) lesions of one nigrostriatal pathway did not reduce the spontaneous release of radioactivity, or the potassium chloride- or amphetamine-induced release of radioactivity from slices of nigra ipsilateral to the lesion after preincubation with [3H]dopamine. The accumulation of radioactivity following incubation of nigral slices from 6-OHDA-lesioned animals with [3H]dopamine was increased when compared to uptake into slices from intact tissue. In synaptosomal preparations of striatum, nomifensine but not desipramine or fluoxetine inhibited [3H]dopamine uptake. In contrast, nomifensine, desipramine, and fluoxetine all inhibited [3H]dopamine uptake in nigral synaptosomal preparations. Following 6-OHDA lesions of one nigrostriatal pathway the uptake of [3H]dopamine into nigral synaptosomal preparations was unchanged but uptake into striatal preparations was substantially decreased. In contrast, bilateral electrolesions of the dorsal and medial raphe nuclei reduced [3H]dopamine uptake into nigral preparations but not into striatal synaptosomes. The uptake of [3H]5-hydroxytryptamine ([3H]5-HT) into synaptosomal preparations of substantia nigra was abolished by fluoxetine and reduced by desipramine, but was unaffected by nomifensine. In contrast, fluoxetine, desipramine, and nomifensine all inhibited [3H]5-HT uptake into striatal synaptosomal preparations. Following 6-OHDA lesions of one nigro-striatal pathway the uptake of [3H]5-HT into nigral synaptosomal preparations was unchanged but uptake into striatal preparations was reduced.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923157     DOI: 10.1111/j.1471-4159.1985.tb05485.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Presynaptic regulation of electrically evoked dopamine overflow in nucleus accumbens: a pharmacological study using fast cyclic voltammetry in vitro.

Authors:  D R Bull; M J Sheehan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

Review 2.  Presynaptic control of serotonin on striatal dopamine function.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Psychopharmacology (Berl)       Date:  2010-10-16       Impact factor: 4.530

3.  Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.

Authors:  Mads Breum Larsen; Mark S Sonders; Ole Valente Mortensen; Gaynor A Larson; Nancy R Zahniser; Susan G Amara
Journal:  J Neurosci       Date:  2011-04-27       Impact factor: 6.167

4.  False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine.

Authors:  T J Feuerstein; G Hertting; A Lupp; B Neufang
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

5.  GBR 13098, a selective dopamine uptake inhibitor; behavioural, biochemical and electrophysiological studies.

Authors:  E Pileblad; G Engberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

6.  Modulation of dopamine and noradrenaline release and of intracellular Ca2+ concentration by presynaptic glutamate receptors in hippocampus.

Authors:  J O Malva; A P Carvalho; C M Carvalho
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  Cholinergic modulation of [3H]dopamine release from dendrosomes of rat substantia nigra.

Authors:  M Marchi; A Augliera; A Codignola; G Lunardi; E Fedele; G Fontana; M Raiteri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

8.  A dynamic role for dopamine receptors in the control of mammalian spinal networks.

Authors:  Simon A Sharples; Nicole E Burma; Joanna Borowska-Fielding; Charlie H T Kwok; Shane E A Eaton; Glen B Baker; Celine Jean-Xavier; Ying Zhang; Tuan Trang; Patrick J Whelan
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.